ChemPartner PharmaTech Co Ltd Total Liabilities
ChemPartner PharmaTech Co Ltd total liabilities. Based on the latest financial reports, ChemPartner PharmaTech Co Ltd (300149) has total liabilities worth CN¥728.59 Million CNY (≈ $106.62 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See how many days can ChemPartner PharmaTech Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.
Total Liabilities of ChemPartner PharmaTech Co Ltd (2007–2025)
Total liabilities of ChemPartner PharmaTech Co Ltd from 2007 to 2025. This chart illustrates how ChemPartner PharmaTech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check ChemPartner PharmaTech Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
ChemPartner PharmaTech Co Ltd Competitors by Total Liabilities
The table below lists competitors of ChemPartner PharmaTech Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jiangsu Province Commun
SHG:603018
|
China | CN¥6.96 Billion |
|
Shanghai Yaohua Pilkington Glass Group Co Ltd A
SHG:600819
|
China | CN¥3.70 Billion |
|
Akva Group
OL:AKVA
|
Norway | Nkr2.87 Billion |
|
Daishin Sec
KO:003540
|
Korea | ₩38.04 Trillion |
|
Sichuan Meifeng Chemical Industry Co Ltd
SHE:000731
|
China | CN¥797.08 Million |
|
DBV Technologies
NASDAQ:DBVT
|
USA | $62.80 Million |
|
Kinko Optical Co Ltd
TW:6209
|
Taiwan | NT$1.36 Billion |
|
Wuxi Xinhongtai ElecTech
SHG:603016
|
China | CN¥197.03 Million |
Liability Composition Analysis (2007–2025)
This chart breaks down ChemPartner PharmaTech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 300149 current and non-current assets.
Liquidity & Leverage Metrics
ChemPartner PharmaTech Co Ltd Total Liabilities Ratios Explained
ChemPartner PharmaTech Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.13 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.57 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.36 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ChemPartner PharmaTech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ChemPartner PharmaTech Co Ltd (2007–2025)
The table below shows the annual total liabilities of ChemPartner PharmaTech Co Ltd from 2007 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥732.59 Million ≈ $107.20 Million |
-3.32% |
| 2024-12-31 | CN¥757.75 Million ≈ $110.88 Million |
-22.16% |
| 2023-12-31 | CN¥973.44 Million ≈ $142.44 Million |
-32.30% |
| 2022-12-31 | CN¥1.44 Billion ≈ $210.42 Million |
-35.48% |
| 2021-12-31 | CN¥2.23 Billion ≈ $326.10 Million |
+33.51% |
| 2020-12-31 | CN¥1.67 Billion ≈ $244.26 Million |
+13.99% |
| 2019-12-31 | CN¥1.46 Billion ≈ $214.28 Million |
+28.09% |
| 2018-12-31 | CN¥1.14 Billion ≈ $167.29 Million |
+450.32% |
| 2017-12-31 | CN¥207.73 Million ≈ $30.40 Million |
+794.10% |
| 2016-12-31 | CN¥23.23 Million ≈ $3.40 Million |
-27.83% |
| 2015-12-31 | CN¥32.19 Million ≈ $4.71 Million |
-27.82% |
| 2014-12-31 | CN¥44.60 Million ≈ $6.53 Million |
+32.36% |
| 2013-12-31 | CN¥33.70 Million ≈ $4.93 Million |
+26.13% |
| 2012-12-31 | CN¥26.72 Million ≈ $3.91 Million |
+19.45% |
| 2011-12-31 | CN¥22.37 Million ≈ $3.27 Million |
+38.75% |
| 2010-12-31 | CN¥16.12 Million ≈ $2.36 Million |
-54.00% |
| 2009-12-31 | CN¥35.04 Million ≈ $5.13 Million |
+22.62% |
| 2008-12-31 | CN¥28.57 Million ≈ $4.18 Million |
-34.36% |
| 2007-12-31 | CN¥43.53 Million ≈ $6.37 Million |
-- |
About ChemPartner PharmaTech Co Ltd
ChemPartner PharmaTech Co.,Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services. The company provides comprehen… Read more